Stem Cells News and Research

RSS
Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth. In addition, in many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive. When a stem cell divides, each new cell has the potential either to remain a stem cell or become another type of cell with a more specialized function, such as a muscle cell, a red blood cell, or a brain cell.
US Equity Holdings announces new funding to launch Aelan Cell Technologies

US Equity Holdings announces new funding to launch Aelan Cell Technologies

Oxygen regulatory pathway can act to trigger tissue regeneration in mice

Oxygen regulatory pathway can act to trigger tissue regeneration in mice

MR Solutions provides advanced preclinical imaging solution at Manchester University

MR Solutions provides advanced preclinical imaging solution at Manchester University

BioLife reports increased use of CryoStor and HypoThermosol biopreservation media products in clinical studies

BioLife reports increased use of CryoStor and HypoThermosol biopreservation media products in clinical studies

Takara Bio Europe launches Cellartis DEF-CS Xeno-Free Culture Medium for iPS cell culture

Takara Bio Europe launches Cellartis DEF-CS Xeno-Free Culture Medium for iPS cell culture

National Psoriasis Foundation awards grants to support psoriatic disease research

National Psoriasis Foundation awards grants to support psoriatic disease research

Scientists identify gene mutation that causes color blindness

Scientists identify gene mutation that causes color blindness

EMA grants Orphan Drug Designation to Stempeucel for treatment of Thromboangiitis Obliterans

EMA grants Orphan Drug Designation to Stempeucel for treatment of Thromboangiitis Obliterans

Maintenance therapy with lenalidomide benefits patients with multiple myeloma

Maintenance therapy with lenalidomide benefits patients with multiple myeloma

Adaptimmune presents clinical results of NY-ESO TCR therapeutic candidate at ASCO 2015

Adaptimmune presents clinical results of NY-ESO TCR therapeutic candidate at ASCO 2015

Pharmacyclics’ Ibrutinib Phase Ib/II data show ibrutinib may be safe and effective in patients with cGVHD

Pharmacyclics’ Ibrutinib Phase Ib/II data show ibrutinib may be safe and effective in patients with cGVHD

Scientists one step closer to understanding how brain regulates memory and mood

Scientists one step closer to understanding how brain regulates memory and mood

Scientists develop human cortical spheroids

Scientists develop human cortical spheroids

Process of aging could be delayed in human cell lines

Process of aging could be delayed in human cell lines

Secret to the life-long activity of a stem cell niche

Secret to the life-long activity of a stem cell niche

Additional preclinical data on DelMar’s VAL-083 to treat temozolomide-resistant GBM presented at AACR

Additional preclinical data on DelMar’s VAL-083 to treat temozolomide-resistant GBM presented at AACR

FLI invites scientific elite to EKF Symposium on Adult Stem Cells in Aging, Diseases and Cancer

FLI invites scientific elite to EKF Symposium on Adult Stem Cells in Aging, Diseases and Cancer

Over 700 Chinese patients with acute myeloid leukemia undergo Microtransplantation treatment

Over 700 Chinese patients with acute myeloid leukemia undergo Microtransplantation treatment

PEPRR intervention successfully reduces stress of cancer caregivers

PEPRR intervention successfully reduces stress of cancer caregivers

KeyGenes platform could be useful for testing quality of stem cell transplants

KeyGenes platform could be useful for testing quality of stem cell transplants

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.